Technical University Of Munich
Clinical trials sponsored by Technical University Of Munich, explained in plain language.
-
New hope for rare Coin-Shaped eczema: drug trial shows promise
Disease control OngoingThis study tests if dupilumab, a drug already approved for eczema, can help people with nummular eczema (coin-shaped patches of itchy skin). About 70 adults with moderate-to-severe disease will receive either the drug or a placebo. The goal is to see if dupilumab reduces skin red…
Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Could a liver drug slow a rare brain disease?
Disease control OngoingThis study tests whether glycerol phenylbutyrate (GPB) can slow corticobasal syndrome (CBS), a rare and fast-progressing brain disease. About 32 adults will receive GPB or a placebo for 26 weeks. The main goal is to see if GPB lowers a marker of nerve damage in the blood.
Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control
Last updated May 12, 2026 13:40 UTC